Investigational Therapy in Mantle Cell Lymphoma: KTE-X19 CAR T-Cell Therapy
home / investigator-perspectives / investigational-therapy-in-mantle-cell-lymphoma-kte-x19-car-t-cell-therapy
Michael Wang, MD, reacts to recent data and the potential to treat patients with relapsed or refractory mantle cell lymphoma with KTE-X19, an investigational CAR T-cell therapy.
